Company

Harbin Gloria Pharmaceuticals Acquires Capital Medical University Patent for RMB 11.15 Million – Backing First‑in‑Class TLK2 Gene Therapy for Glaucoma Neuroprotection
Gloria PharmaceuticalsOphthalmology

Harbin Gloria Pharmaceuticals Acquires Capital Medical University Patent for RMB 11.15 Million – Backing First‑in‑Class TLK2 Gene Therapy for Glaucoma Neuroprotection

Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced that it has signed a Technology Transfer (Patent Right) Contract with Capital Medical University to acquire the patent rights for "A Marker…

Qilu Pharmaceutical's QLS2401 Wins CDE Clinical Trial Approval – Trispecific PSMA/STEAP1/CD3 T‑Cell Engager Targets Metastatic Castration‑Resistant Prostate Cancer

Qilu Pharmaceutical’s QLS2401 Wins CDE Clinical Trial Approval – Trispecific PSMA/STEAP1/CD3 T‑Cell Engager Targets Metastatic Castration‑Resistant Prostate Cancer

CSPC Innovation Pharmaceutical's ADC Candidate SYS6062 Wins NMPA Clinical Trial Approval – Advances in Advanced Solid Tumors

CSPC Innovation Pharmaceutical’s ADC Candidate SYS6062 Wins NMPA Clinical Trial Approval – Advances in Advanced Solid Tumors

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
AbbVieNYSE: ABBV

AbbVie Receives FDA Complete Response Letter for TrenibotE with Manufacturing Clarifications Requested

Regeneron Secures FDA Approval for Otarmeni Gene Therapy and Announces Landmark U.S. Pricing Agreement
Gene therapyNASDAQ: REGN

Regeneron Secures FDA Approval for Otarmeni Gene Therapy and Announces Landmark U.S. Pricing Agreement

Thermo Fisher Scientific Reports 6% Revenue Growth in Q1 2026 Driven by Innovative Product Launches and Strategic AI Collaboration
Finanical ReportsNYSE: TMO

Thermo Fisher Scientific Reports 6% Revenue Growth in Q1 2026 Driven by Innovative Product Launches and Strategic AI Collaboration

HKG: 6600HKG: 6618

SciClone Pharmaceuticals Partners with JD Healthcare to Pioneer Integrated Immune Health Management Model

Show More